Annual EBITDA:
-$420.08M-$35.22M(-9.15%)Summary
- As of today, AGIO annual EBITDA is -$420.08 million, with the most recent change of -$35.22 million (-9.15%) on December 31, 2024.
- During the last 3 years, AGIO annual EBITDA has fallen by -$50.91 million (-13.79%).
- AGIO annual EBITDA is now -2553.72% below its all-time high of -$15.83 million, reached on December 31, 2011.
Performance
AGIO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$115.50M+$10.30M(+8.19%)Summary
- As of today, AGIO quarterly EBITDA is -$115.50 million, with the most recent change of +$10.30 million (+8.19%) on September 30, 2025.
- Over the past year, AGIO quarterly EBITDA has dropped by -$14.03 million (-13.83%).
- AGIO quarterly EBITDA is now -3349.72% below its all-time high of $3.55 million, reached on September 30, 2014.
Performance
AGIO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$470.31M-$14.03M(-3.07%)Summary
- As of today, AGIO TTM EBITDA is -$470.31 million, with the most recent change of -$14.03 million (-3.07%) on September 30, 2025.
- Over the past year, AGIO TTM EBITDA has dropped by -$69.03 million (-17.20%).
- AGIO TTM EBITDA is now -9306.26% below its all-time high of -$5.00 million, reached on March 31, 2012.
Performance
AGIO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
AGIO EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -9.2% | -13.8% | -17.2% |
| 3Y3 Years | -13.8% | -33.4% | -25.1% |
| 5Y5 Years | -36.3% | -52.5% | -39.0% |
AGIO EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -13.8% | at low | -34.0% | +8.2% | -31.8% | at low |
| 5Y | 5-Year | -36.3% | at low | -52.5% | +8.2% | -48.3% | at low |
| All-Time | All-Time | -2553.7% | at low | -3349.7% | +8.2% | -9306.3% | at low |
AGIO EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$115.50M(+8.2%) | -$470.31M(-3.1%) |
| Jun 2025 | - | -$125.80M(-19.4%) | -$456.28M(-5.0%) |
| Mar 2025 | - | -$105.35M(+14.8%) | -$434.71M(-3.5%) |
| Dec 2024 | -$420.08M(-9.2%) | -$123.67M(-21.9%) | -$420.08M(-4.7%) |
| Sep 2024 | - | -$101.47M(+2.6%) | -$401.29M(-0.5%) |
| Jun 2024 | - | -$104.22M(-14.9%) | -$399.10M(-3.9%) |
| Mar 2024 | - | -$90.72M(+13.5%) | -$384.11M(-1.2%) |
| Dec 2023 | -$384.86M(-1.2%) | -$104.87M(-5.6%) | -$379.60M(-2.7%) |
| Sep 2023 | - | -$99.27M(-11.2%) | -$369.52M(-3.6%) |
| Jun 2023 | - | -$89.24M(-3.5%) | -$356.84M(+1.0%) |
| Mar 2023 | - | -$86.22M(+9.1%) | -$360.47M(+2.7%) |
| Dec 2022 | -$380.48M(-3.1%) | -$94.80M(-9.5%) | -$370.49M(+1.4%) |
| Sep 2022 | - | -$86.60M(+6.8%) | -$375.91M(-0.0%) |
| Jun 2022 | - | -$92.87M(+3.5%) | -$375.89M(-1.7%) |
| Mar 2022 | - | -$96.23M(+4.0%) | -$369.55M(-2.8%) |
| Dec 2021 | -$369.18M(-13.2%) | -$100.22M(-15.8%) | -$359.64M(-5.8%) |
| Sep 2021 | - | -$86.57M(-0.1%) | -$339.88M(-3.3%) |
| Jun 2021 | - | -$86.53M(-0.2%) | -$329.02M(-2.5%) |
| Mar 2021 | - | -$86.32M(-7.3%) | -$321.11M(-1.3%) |
| Dec 2020 | -$326.13M(-5.8%) | -$80.45M(-6.3%) | -$317.14M(+6.3%) |
| Sep 2020 | - | -$75.72M(+3.7%) | -$338.47M(+7.9%) |
| Jun 2020 | - | -$78.62M(+4.5%) | -$367.59M(+7.8%) |
| Mar 2020 | - | -$82.35M(+19.1%) | -$398.67M(+2.7%) |
| Dec 2019 | -$308.18M(+9.1%) | -$101.78M(+2.9%) | -$409.71M(-1.8%) |
| Sep 2019 | - | -$104.84M(+4.4%) | -$402.38M(-1.9%) |
| Jun 2019 | - | -$109.70M(-17.5%) | -$394.90M(-10.8%) |
| Mar 2019 | - | -$93.39M(+1.1%) | -$356.41M(-0.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$338.86M(-7.8%) | -$94.44M(+3.0%) | -$355.31M(-1.7%) |
| Sep 2018 | - | -$97.36M(-36.7%) | -$349.34M(-6.1%) |
| Jun 2018 | - | -$71.21M(+22.8%) | -$329.38M(+3.5%) |
| Mar 2018 | - | -$92.29M(-4.3%) | -$341.19M(-8.5%) |
| Dec 2017 | -$314.36M(-61.0%) | -$88.48M(-14.3%) | -$314.36M(-11.6%) |
| Sep 2017 | - | -$77.40M(+6.8%) | -$281.57M(-5.8%) |
| Jun 2017 | - | -$83.03M(-26.8%) | -$266.25M(-11.7%) |
| Mar 2017 | - | -$65.46M(-17.5%) | -$238.38M(-22.1%) |
| Dec 2016 | -$195.28M(-69.3%) | -$55.69M(+10.3%) | -$195.28M(-8.9%) |
| Sep 2016 | - | -$62.08M(-12.5%) | -$179.34M(-14.5%) |
| Jun 2016 | - | -$55.17M(-146.8%) | -$156.69M(-17.9%) |
| Mar 2016 | - | -$22.35M(+43.8%) | -$132.88M(-15.2%) |
| Dec 2015 | -$115.36M(-118.6%) | -$39.75M(-0.8%) | -$115.36M(-13.1%) |
| Sep 2015 | - | -$39.43M(-25.8%) | -$101.97M(-72.9%) |
| Jun 2015 | - | -$31.35M(-549.8%) | -$58.99M(-29.3%) |
| Mar 2015 | - | -$4.83M(+81.7%) | -$45.64M(+13.5%) |
| Dec 2014 | -$52.77M(-40.9%) | -$26.36M(-841.8%) | -$52.77M(-37.8%) |
| Sep 2014 | - | $3.55M(+119.7%) | -$38.30M(+27.1%) |
| Jun 2014 | - | -$18.00M(-50.6%) | -$52.55M(-23.1%) |
| Mar 2014 | - | -$11.95M(-0.4%) | -$42.70M(-14.0%) |
| Dec 2013 | -$37.44M(-71.6%) | -$11.90M(-11.3%) | -$37.44M(-46.6%) |
| Sep 2013 | - | -$10.69M(-31.2%) | -$25.54M(-72.0%) |
| Jun 2013 | - | -$8.15M(-21.7%) | -$14.85M(-18.3%) |
| Mar 2013 | - | -$6.70M(-14.5%) | -$12.55M(-15.6%) |
| Dec 2012 | -$21.82M(-37.8%) | - | - |
| Jun 2012 | - | -$5.85M(-17.0%) | -$10.85M(-117.0%) |
| Mar 2012 | - | -$5.00M | -$5.00M |
| Dec 2011 | -$15.83M | - | - |
FAQ
- What is Agios Pharmaceuticals, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Agios Pharmaceuticals, Inc.?
- What is Agios Pharmaceuticals, Inc. annual EBITDA year-on-year change?
- What is Agios Pharmaceuticals, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Agios Pharmaceuticals, Inc.?
- What is Agios Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
- What is Agios Pharmaceuticals, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Agios Pharmaceuticals, Inc.?
- What is Agios Pharmaceuticals, Inc. TTM EBITDA year-on-year change?
What is Agios Pharmaceuticals, Inc. annual EBITDA?
The current annual EBITDA of AGIO is -$420.08M
What is the all-time high annual EBITDA for Agios Pharmaceuticals, Inc.?
Agios Pharmaceuticals, Inc. all-time high annual EBITDA is -$15.83M
What is Agios Pharmaceuticals, Inc. annual EBITDA year-on-year change?
Over the past year, AGIO annual EBITDA has changed by -$35.22M (-9.15%)
What is Agios Pharmaceuticals, Inc. quarterly EBITDA?
The current quarterly EBITDA of AGIO is -$115.50M
What is the all-time high quarterly EBITDA for Agios Pharmaceuticals, Inc.?
Agios Pharmaceuticals, Inc. all-time high quarterly EBITDA is $3.55M
What is Agios Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
Over the past year, AGIO quarterly EBITDA has changed by -$14.03M (-13.83%)
What is Agios Pharmaceuticals, Inc. TTM EBITDA?
The current TTM EBITDA of AGIO is -$470.31M
What is the all-time high TTM EBITDA for Agios Pharmaceuticals, Inc.?
Agios Pharmaceuticals, Inc. all-time high TTM EBITDA is -$5.00M
What is Agios Pharmaceuticals, Inc. TTM EBITDA year-on-year change?
Over the past year, AGIO TTM EBITDA has changed by -$69.03M (-17.20%)